Myocarditis in systemic diseases and the role of cardiovascular magnetic resonance

Hellenic Journal of Cardiology

Volumn 53, Issue 2, 2012, Pages 142-147

  Mavrogeni, Sophie ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Cardiovascular magnetic resonance; Myocarditis; Systemic diseases

Indexed keywords

CORTICOSTEROID; GADOLINIUM; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; STEROID;

AORTA ARCH SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE MYOCARDITIS; AUTOIMMUNE THYROIDITIS; BECKER MUSCULAR DYSTROPHY; CARDIAC SARCOIDOSIS; CARDIOVASCULAR MAGNETIC RESONANCE; CELIAC DISEASE; CHURG STRAUSS SYNDROME; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DUCHENNE MUSCULAR DYSTROPHY; HEART EDEMA; HEART VENTRICLE TACHYCARDIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL MYOCARDITIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYASTHENIA GRAVIS; MYOCARDITIS; MYOSITIS; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SCLERODERMA MYOCARDITIS; SENSITIVITY AND SPECIFICITY; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; THALASSEMIA; THYMOMA;

AUTOIMMUNE DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFECTION; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDITIS; MYOCARDIUM; REPRODUCIBILITY OF RESULTS;

EID: 84859958005     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation. 2001; 104: 1076-1082.
2. Mavrogeni S, Manoussakis MN. Myocarditis as a complication of influenza A (H1N1): evaluation using cardiovascular magnetic resonance imaging. Hellenic J Cardiol. 2010; 51: 379-380.
3. Yilmaz A, Klingel K, Kandolf R, Sechtem U. Imaging in inflammatory heart disease: from the past to current clinical practice. Hellenic J Cardiol. 2009; 50: 449-460.
4. Chrysohoou C, Tsiamis E, Brili S, Barbetseas J, Stefanadis C. Acute myocarditis from coxsackie infection, mimicking subendocardial ischaemia. Hellenic J Cardiol. 2009; 50: 147-150.
5. Xanthos T, Lelovas P, Kantsos H, Dontas I, Perrea D, Kouskouni E. Lyme carditis: complete atrioventricular dissociation with need for temporary pacing. Hellenic J Cardiol. 2006; 47: 313-316.
6. Karatolios K, Pankuweit S, Kisselbach C, Maisch B. Inflammatory cardiomyopathy. Hellenic J Cardiol. 2006; 47: 54-65.
7. Mavrogeni S, Manoussakis MN, Karagiorga TC, et al. Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Arthritis Rheum. 2009; 61: 1121-1129.
8. Mavrogeni S, Papadopoulos G, Karanasios E, Georgakopoulos D, Manoussakis MN. Microscopic polyangiitis and Kawasaki disease without overt clinical cardiovascular manifestations and with abnormal cardiovascular magnetic resonance findings. Int J Cardiol. 2010; 141: e17-19.
9. Mavrogeni S, Tsirogianni AK, Gialafos EJ, Manoussakis MN. Detection of myocardial inflammation by contrast-enhanced MRI in a patient with Churg-Strauss syndrome. Int J Cardiol. 2009; 131: e54-55.
10. Abdel-Aty H, Siegle N, Natusch A, et al. Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach. Lupus. 2008; 17: 561-567.
11. Singh JA, Woodard PK, Dávila-Román VG, et al. Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report. Lupus. 2005; 14: 137-144.
12. Guillevin L, Dörner T. Vasculitis: mechanisms involved and clinical manifestations. Arthritis Res Ther. 2007; 9 Suppl 2: S9.
13. Pagnoux C, Guillevin L. Cardiac involvement in small and medium-sized vessel vasculitides. Lupus 2005; 14: 718-722.
14. Mavrogeni S, Bratis K, Karanasios E, et al. CMR evaluation of cardiac involvement during the convalescence of Kawasaki disease. JACC Cardiovasc Imaging. 2011; 4: 1140-1141.
15. Szczeklik W, Miszalski-Jamka T, Mastalerz L, et al. Multimodality assessment of cardiac involvement in Churg-Strauss syndrome patients in clinical remission. Circ J. 2011; 75: 649-655.
16. Looi JL, Ruygrok P, Royle G, Raos Z, Hood C, Kerr AJ. Acute eosinophilic endomyocarditis: early diagnosis and localisation of the lesion by cardiac magnetic resonance imaging. Int J Cardiovasc Imaging. 2010; 26 Suppl 1: 151-154.
17. Yeen WC, Haas G, Mehmood SA, Crestanello JA. Relapse of giant cell myocarditis supported with veno-arterial extracorporeal membrane oxygenation. Interact Cardiovasc Thorac Surg. 2011; 12: 829-831.
18. Cooper LT. Myocarditis. N Engl J Med. 2009; 360: 1526-1538.
19. West SG, Killian PJ, Lawless OJ. Association of myositis and myocarditis in progressive systemic sclerosis. Arthritis Rheum. 1981; 24: 662-668.
20. Kerr LD, Spiera H. Myocarditis as a complication in scleroderma patients with myositis. Clin Cardiol. 1993; 16: 895-899.
21. Al-mashaleh M, Bak H, Moore J, Manolios N, Englert H. Resolution of sclerodermatous myocarditis after autologous stem cell transplantation. Ann Rheum Dis. 2006; 65: 1247-1248.
22. Slack JD, Waller B. Acute congestive heart failure due to the arteritis of rheumatoid arthritis: early diagnosis by endomyocardial biopsy: a case report. Angiology.1986; 37: 477-482.
23. Miller JJ, French JW. Myocarditis in juvenile rheumatoid arthritis. Am J Dis Child. 1977; 131: 205-209.
24. Talwar KK, Chopra P, Narula J, et al. Myocardial involvement and its response to immunosuppressive therapy in nonspecific aortoarteritis (Takayasu's disease)-a study by endomyocardial biopsy. Int J Cardiol. 1988; 21: 323-334.
25. Takeda N, Takahashi T, Seko Y, et al. Takayasu myocarditis mediated by cytotoxic T lymphocytes. Intern Med. 2005; 44: 256-260.
26. Dumarey N, Tang BN, Goldman S, et al. Papillary muscle inflammation in Takayasu's arteritis revealed by FDG-PET. Eur Heart J. 2007; 28: 1011.
27. Mavrogeni S, Manoussakis MN. Myocarditis and subclavian stenosis in Takayasu arteritis. Int J Cardiol. 2011; 148: 223-224.
28. Talwar KK, Chopra P, Narula J, et al. Myocardial involvement and its response to immunosuppressive therapy in nonspecific aortoarteritis (Takayasu's disease)-a study by endomyocardial biopsy. Int J Cardiol. 1988; 21: 323-334.
29. Gottdiener JS, Sherber HS, Hawley RJ, Engel WK. Cardiac manifestations in polymyositis. Am J Cardiol. 1978; 41: 1141-1149.
30. Gonzalez-Lopez L, Gamez-Nava JI, Sanchez L, et al. Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol. 1996; 14: 373-379.
31. Lundberg IE. The heart in dermatomyositis and polymyositis. Rheumatology (Oxford). 2006; 45 Suppl 4: iv18-21.
32. Cǎlin C, Savu O, Dumitru D, et al. Cardiac involvement in myasthenia gravis-is there a specific pattern? Rom J Intern Med. 2009; 47: 179-189.
33. Mavrogeni S, Tzelepis GE, Athanasopoulos G, et al. Cardiac and sternocleidomastoid muscle involvement in Duchenne muscular dystrophy: an MRI study. Chest. 2005; 127: 143-148.
34. Badorff C, Knowlton KU. Dystrophin disruption in enterovirus- induced myocarditis and dilated cardiomyopathy: from bench to bedside. Med Microbiol Immunol. 2004; 193: 121-126.
35. Xiong D, Lee GH, Badorff C, et al. Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: a genetic predisposition to viral heart disease. Nat Med. 2002; 8: 872-877.
36. Mavrogeni S, Papavasiliou A, Spargias K, et al. Myocardial inflammation in Duchenne Muscular Dystrophy as a precipitating factor for heart failure: a prospective study. BMC Neurol. 2010; 10: 33.
37. Fatourechi V, Edwards WD. Graves' disease and low-output cardiac dysfunction: implications for autoimmune disease in endomyocardial biopsy tissue from eleven patients. Thyroid. 2000; 10: 601-605.
38. Di Marco V, Capra M, Angelucci E, et al. Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel. Blood. 2010; 116: 2875-2883.
39. Kremastinos DT, Tiniakos G, Theodorakis GN, Katritsis DG, Toutouzas PK. Myocarditis in beta-thalassemia major. A cause of heart failure. Circulation. 1995; 91: 66-71.
40. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009; 53: 1475-1487.
41. Gagliardi MG, Polletta B, Di Renzi P. MRI for the diagnosis and follow-up of myocarditis. Circulation. 1999; 99: 458-459.
42. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004; 109: 1250-1258.
43. Verhaert D, Thavendiranathan P, Giri S, et al. Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging. 2011; 4: 269-278.
44. Giri S, Chung YC, Merchant A, et al. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson. 2009; 11: 56.
45. Iles L, Pfluger H, Phrommintikul A, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008; 52: 1574-1580.
46. Ohata S, Shimada T, Shimizu H, Murakami Y, Matsuno Y. Myocarditis associated with polymyositis diagnosed by gadolinium- DTPA enhanced magnetic resonance imaging. J Rheumatol. 2002; 29: 861-862.
47. Allanore Y, Vignaux O, Arnaud L, et al. Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Ann Rheum Dis. 2006; 65: 249-252.
48. Mavrogeni S, Bratis K, I. Iakovou, G. Kolovou. Systemic lupus erythematosus. Two sides of the same coin evaluated by cardiovascular magnetic resonance imaging. Lupus. 2011; 20: 1338-1339.
49. Mavrogeni S, Spargias K, Markussis V, et al. Myocardial inflammation in autoimmune diseases: investigation by cardiovascular magnetic resonance and endomyocardial biopsy. Inflamm Allergy Drug Targets. 2009; 8: 390-397.
50. Mavrogeni S, Papadopoulos G, Karanasios E, Cokkinos DV. Cardiovascular magnetic resonance imaging reveals myocardial inflammation and coronary artery ectasia during the acute phase of Kawasaki disease. Int J Cardiol. 2009; 136: e51-53.
51. Mavrogeni S, Papadopoulos G, Douskou M, et al. Magnetic resonance angiography, function and viability evaluation in patients with Kawasaki disease. J Cardiovasc Magn Reson. 2006; 8: 493-498.
52. Mavrogeni S, Papadopoulos G, Douskou M, et al. Magnetic resonance angiography is equivalent to X-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease. J Am Coll Cardiol. 2004; 43: 649-652.
53. Laissy JP, Messin B, Varenne O, et al. MRI of acute myocarditis: a comprehensive approach based on various imaging sequences. Chest. 2002; 122: 1638-1648.
54. Mavrogeni S, Papavasiliou A, Skouteli E, Magoutas A, Dangas G. Cardiovascular magnetic resonance imaging evaluation of two families with Becker muscular dystrophy. Neuromuscul Disord. 2010; 20: 717-719.
55. Cheong BY, Muthupillai R, Nemeth M, et al. The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2009; 26: 39-46.